SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-006377
Filing Date
2023-03-07
Accepted
2023-03-07 07:30:59
Documents
78
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tcrt-20221231.htm   iXBRL 10-K 3305318
2 EX-23.1 tcrt-ex23_1.htm EX-23 4629
3 EX-31.1 tcrt-ex31_1.htm EX-31 17643
4 EX-32.1 tcrt-ex32_1.htm EX-32 9579
5 GRAPHIC img159912857_0.jpg GRAPHIC 42879
6 GRAPHIC img159912857_1.jpg GRAPHIC 361119
  Complete submission text file 0000950170-23-006377.txt   12747700

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrt-20221231_cal.xml EX-101.CAL 51588
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrt-20221231_lab.xml EX-101.LAB 682122
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrt-20221231_pre.xml EX-101.PRE 547289
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrt-20221231.xsd EX-101.SCH 85135
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrt-20221231_def.xml EX-101.DEF 402391
72 EXTRACTED XBRL INSTANCE DOCUMENT tcrt-20221231_htm.xml XML 2012155
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33038 | Film No.: 23711040
SIC: 2834 Pharmaceutical Preparations